Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02187770 · ClinicalTrials.gov registry record
Precision of IMED-4 Lung Fluid Measurements
A clinical trial of Dyspnea and Pulmonary Congestion, sponsored by Intersection Medical.
- Completed
- Registry status
- 46
- Enrollment target
- 3
- Study locations
NCT02187770 is a study of Dyspnea and Pulmonary Congestion that has completed, run by Intersection Medical. The registered enrollment target is 46 participants, below the 304-participant average among 23 other Dyspnea trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT02187770, a study of Dyspnea and Pulmonary Congestion, has completed, sponsored by Intersection Medical.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to determine if IMED-4 recordings have sufficient precision to detect a clinically significant change in lung fluid status in acute heart failure syndrome with pulmonary congestion.
Conditions Studied
Interventions
- DEVICE IMED-4
Study Locations (3)
Massachusetts
- Mass General Hospital - Boston
Michigan
- Henry Ford Hospital - Detroit
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02187770
The ClinicalTrials.gov registry entry for NCT02187770 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 23 other Dyspnea trials with a reported enrollment target (85% lower). The listed sponsor is Intersection Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Dyspnea appearing as the primary indexed condition, and to 1 intervention - of which IMED-4 is the first listed.
NCT02187770 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Michigan, Ohio.
Frequently Asked Questions
What is clinical trial NCT02187770 about?
NCT02187770 is a clinical study titled "Precision of IMED-4 Lung Fluid Measurements". The purpose of this study is to determine if IMED-4 recordings have sufficient precision to detect a clinically significant change in lung fluid status in acute heart failure syndrome with pulmonary congestion.
What is the current status of trial NCT02187770?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2014-07. Estimated completion is 2015-10.
What conditions does trial NCT02187770 study?
This clinical trial studies the following conditions: Dyspnea, Pulmonary Congestion, Acute Heart Failure Syndrome.
What interventions are being tested in trial NCT02187770?
The interventions under investigation include: IMED-4 (DEVICE).
Who is sponsoring clinical trial NCT02187770?
This trial is sponsored by Intersection Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02187770 being conducted?
This trial has 3 study locations across Massachusetts, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
RECRUITING · Phase 2
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
RECRUITING
-
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
RECRUITING · Phase 2
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.